- Insulet Corporation (NASDAQ:PODD) announced a Medical Device Correction for the Omnipod 5 Automated Insulin Delivery System because of an issue with the Omnipod 5 Controller charging port and cable.
- Insulet has received 24 reports that the Omnipod 5 Controller charging port (USB-C port) or cable (USB cable) is melting, deforming or discoloring due to heat generated by a poor connection between the cable and the port.
- Related: Insulet Shares Jump After Q3 Earnings Surpass Expectations, Improved Annual Guidance.
- The excess heat may cause minor burns if those areas of the Controller are touched or could lead to a fire. No serious injuries have been reported to Insulet as a result of this issue.
- Omnipod 5 users are being notified by email with instructions on detecting and reducing the risk of an issue with the charging port or cable.
- This does not impact the Omnipod 5 Pod, the Omnipod DASH Insulin Management System, the Omnipod Insulin Management System, or compatible Android smartphone devices with the Omnipod 5 App installed.
- These actions are taken voluntarily with the knowledge of the FDA.
- Price Action: PODD shares are up 2.82% at $298.27 on the last check Tuesday.
Viatris To Divest OTC, Women’s Healthcare, And API Businesses In Strategic Move, For Up To $6.94B Of Total Gross Proceeds
Total Gross Proceeds From All Divestitures, Including the 2022 Divestiture of the Company's Biosimilars Business, and the Estimated Retained Value are in Line with the Company's Previously Communicated
